1. Abel, P. D., Hall, R. R., Williams, G.: Should pT1 TCC of bladder still be classified as a superficial.Br. J. Urol., 62, 103 (1988).
2. Adolphs, H. D., Bastian, H. P.: Chemoimmunoprophylaxis of superficial bladder tumors.J. Urol., 129, 29 (1983).
3. Baccon-Gibod, L. B., Lelev, I. M., Herve, I. M., Belas, M., Steg, A.: Bladder tumours invading the lamina propria (State: T1): Influence of endovesical BCG therapy on recurrence. In: EORTC Genitourinary Group Monograph 6. Alan R. Liss, Inc., New York 1989, p. 161.
4. Brosman, S.: The influence of Tice Strain BCG treatment in patients with transitional cell carcinoma in situ. In: EORTC Genitourinary Group Monograph 6. Alan R. Liss, Inc., New York, 1989, p. 193.
5. England, H. R., Paris, A. M., Blandy, J. B.: The correlation of T1 bladder tumour history with prognosis and follow up requirements.Br. J. Urol., 53, 593 (1981).